Politics
FDA approves first mRNA flu vaccine
The Hill·August 6, 2026·1 min read
The FDA approved the nation's first mRNA flu vaccine, manufactured by Moderna, late Wednesday. The shot was approved for two age groups: people aged 50 to 64 and those 65 and older. Moderna will conduct a postmarket clinical trial to confirm the vaccine's effectiveness in these populations.
Read at The HillDaily crypto arcade
Read the news, then play it.
Chainshorts turns crypto headlines into a daily game. Catch up in 60 words, then jump into daily lucky draws for a shot at the pot.